Market Research NewsNews

Ophthalmology Drugs & Devices Market to Reach $36.95. billion by 2025: CAGR 4.3% | A report by Carl Zeiss Meditec AG, Alcon Inc, Johnson & Johnson, Topcon Corporation, Nidek, Haag-Streit Group and others

Ophthalmology Drugs & Devices market report is a comprehensive study on how the Pharmaceutical industry is changing because of Ophthalmology Drugs & Devices market. There are several systematic information in the report, like what the CAGR values are going to be in the forecast years of 2019-2025, and what the market definition, classifications, applications and market trends mean and how to use them to achieve a greater edge on the key players and brands whose company profiles are included in the report.

This report also contains all the recent developments, product launches, joint ventures, merges and accusations by the top brands and players. All the way by also informing what the market drivers and restrains are with help of SWOT analysis.

Market Analysis:

Global Ophthalmology Drugs & Devices Market is expected to reach USD 36.95. billion by 2025, from USD 27.52 billion in 2017 growing at a CAGR of 4.3% during the forecast period of 2018 to 2025. The upcoming market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Soeak to Author

Key Players:

  • Carl Zeiss Meditec AG
  • Alcon Inc
  • Johnson & Johnson
  • Topcon Corporation
  • Nidek
  • Haag-Streit Group
  • Ziemer Ophthalmology Systems AG
  • Essilor International SA
  • Bausch & Lomb Inc
  • VisionCare
  • Akorn
  • Regeneron
  • Bausch Health
  • Bayer AG
  • Acucela
  • Nicox
  • Novartis AG
  • Santen Pharmaceutical
  • Merck
  • IRIDEX Corporation
  • STAAR SURGICAL and more

Key Developments in the Market:

In March 2012, Nicox (France) enters completed the acquisition of Altacor (U.K.). Through this acquisition the company has ha expanded it’s international ophthalmology business.

In May 2011, Akorn Inc (U.S.) completed the acquisition of Advanced Vision Research (U.S). Through this acquisition the Akorn Inc had expanded its business in ophthalmology market. the compmay had also planned to launch new Consumer Health Division OTC eyecare market, pending the acquisition of AVR.

In October 2011, Akorn Inc (U.S.) completed the acquisition of Kilitch Drugs (India). Through this acquisition the company had expanded its product portfolio.

Get detailed free TOC @

Major Market Drivers and Restraints:

  • Increase in prevalence rates of eye diseases
  • Increasing prevalence of diabetes increases the probability of ophthalmic disorders
  • Rising geriatric population
  • Increasing in technology advancement
  • Increase in healthcare expenditure
  • Downward pricing pressure owing to its commodity nature
  • Increasing substitutes to sutures such as hemostats and surgical staplers


The global ophthalmology drugs and devices equipment market is segmented into

  • drug delivery types
  • disease type
  • retinal disorders
  • drug therapeutic class
  • product type

Based on drug delivery types the market is segmented into

  • capsules & tablets
  • gels
  • eye drops eye ointments
  • eye solutions) (disposable, reusable)

On the basis of disease type, the market is segmented into

  • dry eye
  • glaucoma
  • infection/inflammation
  • retinal disorders

On the basis of retinal disorders, the market is segmented into

  • wet age-related macular degeneration
  • dry age-related macular degeneration
  • diabetic retinopathy

On the basis of end users, the market is segmented into

  • hospitals
  • ambulatory centers
  • clinics
  • community healthcare
  • others

Based on geography, the market report covers data points for 28 countries across multiple geographies namely

  • North America
  • South America
  • Europe
  • Asia-Pacific
  • Middle East
  • Africa

Some of the major countries covered in this report are

  • US., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa and, Brazil among others.

Customization of the Report: 

The report includes the complete segmentation displayed above across all above mentioned countries. All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

Reasons to Purchase this Report

  • Current and future of global ophthalmology drugs and devices equipment market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
  • Regions/countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Speak to Author


Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *